Innate anti-viral immunity is associated with the protection elicited by the Simian Immunodeficiency Virus (SIV) live attenuated virus vaccine in cynomolgus monkeys

Medical Science Monitor

Volumn 12, Issue 10, 2006, Pages

  Goletti, Delia ^a   Macchia, Iole ^b   Leone, Pasqualina ^b   Pace, Monica ^c   Sernicola, Leonardo ^b   Pavone Cossut, Maria Rosaria ^b   Maggiorella, Maria Teresa ^b   Cafaro, Aurelio ^b   Ensoli, Barbara ^b   Titti, Fausto ^b  

^a National Institute of Infectious Disease L Spallanzani   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c ITALIAN NATIONAL INSTITUTE OF STATISTICS   (Italy)

Author keywords

Attenuated; CD8+ T lymphocytes; Immunity; Natural; Simian Immunodeficiency Virus; Vaccines

Indexed keywords

BETA CHEMOKINE; CD8 ANTIGEN; GAMMA INTERFERON; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNITY; MALE; MONKEY; MONOCYTE; NONHUMAN; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL-FREE SYSTEM; CELLS, CULTURED; GENE PRODUCTS, NEF; IMMUNITY, INNATE; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERFERON-GAMMA; MACACA FASCICULARIS; MALE; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES; VIRUS REPLICATION;

EID: 33749650756     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Cranage MP, Whatmore AM, Sharpe SA et al: Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology, 1997; 229: 143-54
2. Sernicola L, Corrias F, Koanga-Mogtomo ML et al: Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen. Virology, 1999; 256: 291-302
3. Titti F, Sernicola L, Geraci A et al: Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys. J Gen Virol, 1997; 78(Pt 10): 2529-39
4. Langlois AJ, Desrosiers RC, Lewis MG et al: Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus. J Virol, 1998; 72: 6950-55
5. Nixon DF, Donahoe SM, Kakimoto WM et al: Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine. Virology, 2000; 266: 203-10
6. Almond N, Corcoran T, Hull R et al: Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells. J Med Primatol, 1997; 26: 34-43
7. Stebbings R, Stott J, Almond N et al: Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses, 1998; 14: 1187-98
8. Stebbings RJ, Almond NM, Stott EJ et al: Mechanisms of protection induced by attenuated simian immunodeficiency virus. Virology, 2002; 296: 338-53
9. Levy JA: The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol, 2003; 24: 628-32
10. Mackewicz C,.Levy JA: CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res Hum Retroviruses, 1992; 8: 1039-50
11. Mackewicz CE, Ortega HW, Levy JA: CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest, 1991; 87: 1462-66
12. Ahmed RK, Norrgren H, da Silva Z et al: Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals. Scand J Immunol, 2005; 61: 63-71
13. Le BS, Fevrier M, Callebaut C et al: CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription. J Virol, 2000; 74: 4456-64
14. Mackewicz CE, Patterson BK, Lee SA, Levy JA: CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. J Gen Virol, 2000; 81: 1261-64
15. Pinto LA, Blazevic V, Patterson BK et al: Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation. J Virol, 2000; 74: 4505-11
16. Tomaras GD, Lacey SF, McDanal CB et al: CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proc Natl Acad Sci USA, 2000; 97: 3503-8
17. Kornfeld C, Ploquin MJ, Pandrea I et al: Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest, 2005; 115: 1082-91
18. Pandrea I, Kornfeld C, Ploquin MJ et al: Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol, 2005; 79: 6249-59
19. Cocchi F, DeVico AL, Garzino-Demo A et al: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science, 1995; 270: 1811-15
20. Kinter AL, Ostrowski M, Goletti D et al: HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci USA, 1996; 93: 14076-81
21. Paliard X, Lee AY, Walker CM: RANTES, MIP-1 alpha and MIP-1 beta are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clones. AIDS, 1996; 10: 1317-21
22. Powell JD, Bednarik DP, Folks TM et al: Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primates. Clin Exp Immunol, 1993; 91: 473-81
23. La Franco-Scheuch L, Abel K, Makori N et al: High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum. J Virol, 2004; 78: 6399-408
24. Geiben-Lynn R, Brown N, Walker BD, Luster AD: Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor. J Biol Chem, 2002; 277: 42352-57
25. Zhang L, Yu W, He T et al: Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science, 2002; 298: 995-1000
26. Barker E, Mackewicz CE, Levy JA: Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA, 1995; 92: 11135-39
27. Gauduin MC, Glickman RL, Ahmad S et al: Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production. Proc Natl Acad Sci USA, 1999; 96: 14031-36
28. Baroncelli S, Panzini G, Geraci A et al: Longitudinal characterization of CD4, CD8 T-cell subsets and of haematological parameters in healthy newborns of cynomolgus monkeys. Vet Immunol Immunopathol, 1997; 59: 141-50
29. Reimann KA, Li JT, Veazey R et al: A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol, 1996; 70: 6922-28
30. Cafaro A, Caputo A, Fracasso C et al: Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med, 1999; 5: 643-50
31. Salter RD, Alexander J, Levine F et al: Evidence for two trans-acting genes regulating HLA class II antigen expression. J Immunol, 1985; 135: 4235-38
32. Negri DR, Baroncelli S, Catone S et al: Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge. J Gen Virol, 2004; 85: 1191-201
33. Reed RJ, Muench H: A simple method of estimating fifty per cent endpoints. Am J Hygiene, 1938; 493-97
34. Butera ST, Perez VL, Wu BY et al: Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. J Virol, 1991; 65(9): 4645-53
35. Blackbourn DJ, Locher CP, Ramachandran B et al: CD8+ cells from HIV-2-infected baboons control HIV replication. AIDS, 1997; 11: 737-46
36. Medzhitov R, Janeway CA Jr: Innate immunity: the virtues of a nonclonal system of recognition. Cell, 1997; 91: 295-98
37. Lehner T, Wang Y, Cranage M et al: Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med, 1996; 2: 767-75
38. Kirchhoff F, Pohlmann S, Hamacher M et al: Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J Virol, 1997; 71: 6509-16
39. Ahmed RK, Nilsson C, Wang Y te al: Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge. J Gen Virol, 1999; 80(Pt 7): 1569-74
40. Ahmed RK, Nilsson C, Biberfeld G, Thorstensson R: Role of CD8+ cell-produced anti-viral factors in protective immunity in HIV-2-exposed but seronegative macaques resistant to intrarectal SIVsm challenge. Scand J Immunol, 2001; 53: 245-53
41. Mackewicz CE, Barker E, Greco G te al: Do beta-chemokines have clinical relevance in HIV infection? J Clin Invest, 1997; 100: 921-30
42. Fan J, Nishanian P, Breen EC te al: Cytokine gene expression in normal human lymphocytes in response to stimulation. Clin Diagn Lab Immunol, 1998; 5: 335-40
43. Kunkel SL: Th1- and Th2-type cytokines regulate chemokine expression. Biol Signals, 1996; 5: 197-202
44. Schrum S, Probst P, Fleischer B, Zipfel PF: Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol, 1996; 157: 3598-604
45. Das UN: COX-2 inhibitors and metabolism of essential fatty acids. Med Sci Monit, 2005; 11(7): RA233-37
46. Benz D, Cadet P, Mantione K te al: Tonal nitric oxide and health: antibacterial and -viral actions and implications for HIV. Med Sci Monit, 2002; 8(2): RA27-31
47. Torre D, Pugliese A, Speranza F: Role of nitric oxide in HIV-1 infection: friend or foe? Lancet Infect Dis, 2002; 2: 273-80
48. Bogdan C: Nitric oxide and the immune response. Nat Immunol, 2001; 2: 907-16
49. Galkina SI, Dormeneva EV, Bachschmid M te al: Endothelium-leukocyte interactions under the influence of the superoxide-nitrogen monoxide system. Med Sci Monit, 2004; 10(9): BR307-16
50. Ibiza S, Victor VM, Bosca I et al: Endothelial nitric oxide synthase regulates T cell receptor signaling at the immunological synapse. Immunity, 2006; 24: 753-65
51. Mackewicz CE, Ortega H, Levy JA: Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. Cell Immunol, 1994; 153: 329-43
52. Chang TL, Francois F, Mosoian A, Klotman ME: CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol, 2003; 77: 6777-84
53. Mackewicz CE, Yuan J, Tran P et al: alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS, 2003; 17: F23-32
54. Zhang L, Lopez P, He T te al: Retraction of an interpretation. Science, 2004; 303: 467
55. Dioszeghy V, Benlhassan-Chahour K, Delache B et al: Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression. J Virol, 2006; 80: 236-45
56. Locher CP, Blackbourn DJ, Levy JA: Suppression of human immunodeficiency virus type 1 replication by a soluble factor produced by CD8+ lymphocytes from HIV-2-infected baboons. Immunol Lett, 1999; 66: 151-57
57. Heeney JL, Teeuwsen VJ, van GM et al: beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc Natl Acad Sci USA, 1998; 95: 10803-8
58. Baba TW, Liska V, Khimani AH et al: Live attenuated, multiple deletes simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med, 1999; 5: 194-203
59. Michelini Z, Negri DR, Baroncelli S et al: T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge. J Med Primatol, 2004; 33: 251-61